249 related articles for article (PubMed ID: 31634201)
1. T cells with high PD-1 expression are associated with lower HIV-specific immune responses despite long-term antiretroviral therapy.
Macatangay BJC; Gandhi RT; Jones RB; Mcmahon DK; Lalama CM; Bosch RJ; Cyktor JC; Thomas AS; Borowski L; Riddler SA; Hogg E; Stevenson E; Eron JJ; Mellors JW; Rinaldo CR;
AIDS; 2020 Jan; 34(1):15-24. PubMed ID: 31634201
[TBL] [Abstract][Full Text] [Related]
2. Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4 T cell loss rates in human immunodeficiency virus-1 infection.
Pettersen FO; Taskén K; Kvale D
Clin Exp Immunol; 2010 Aug; 161(2):315-23. PubMed ID: 20491784
[TBL] [Abstract][Full Text] [Related]
3. Subclinical Cytomegalovirus DNA Is Associated with CD4 T Cell Activation and Impaired CD8 T Cell CD107a Expression in People Living with HIV despite Early Antiretroviral Therapy.
Christensen-Quick A; Massanella M; Frick A; Rawlings SA; Spina C; Vargas-Meneses M; Schrier R; Nakazawa M; Anderson C; Gianella S
J Virol; 2019 Jul; 93(13):. PubMed ID: 31019052
[TBL] [Abstract][Full Text] [Related]
4. Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus-Infected Individuals Receiving Suppressive Antiretroviral Therapy.
Khoury G; Fromentin R; Solomon A; Hartogensis W; Killian M; Hoh R; Somsouk M; Hunt PW; Girling V; Sinclair E; Bacchetti P; Anderson JL; Hecht FM; Deeks SG; Cameron PU; Chomont N; Lewin SR
J Infect Dis; 2017 Mar; 215(6):911-919. PubMed ID: 28453847
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Gag- and Env-Specific CD8+ T Cell Responses in ART-Naïve HIV-Infected Patients: Potential Implications for Individualized Immunotherapy.
Prebensen C; Lind A; Dyrhol-Riise AM; Kvale D
PLoS One; 2016; 11(4):e0153849. PubMed ID: 27128502
[TBL] [Abstract][Full Text] [Related]
6. Reversal of the CD8
Li J; Huang HH; Tu B; Zhou MJ; Hu W; Fu YL; Li XY; Yang T; Song JW; Fan X; Jiao YM; Xu RN; Zhang JY; Zhou CB; Yuan JH; Zhen C; Shi M; Wang FS; Zhang C
Front Immunol; 2021; 12():687296. PubMed ID: 34177939
[TBL] [Abstract][Full Text] [Related]
7. Implications of Immune Checkpoint Expression During Aging in HIV-Infected People on Antiretroviral Therapy.
de Armas LR; Pallikkuth S; Rinaldi S; Pahwa R; Pahwa S
AIDS Res Hum Retroviruses; 2019; 35(11-12):1112-1122. PubMed ID: 31578868
[TBL] [Abstract][Full Text] [Related]
8. Prolonged Antiretroviral Therapy in Adolescents With Vertical HIV Infection Leads to Different Cytokine Profiles Depending on Viremia Persistence.
Munhoz LGC; Garcia Spina F; Machado DM; Gouvea A; Succi RCM; Diaz RS; De Moraes-Pinto MI
Pediatr Infect Dis J; 2019 Nov; 38(11):1115-1120. PubMed ID: 31626046
[TBL] [Abstract][Full Text] [Related]
9. Soluble immune checkpoints as correlates for HIV persistence and T cell function in people with HIV on antiretroviral therapy.
Chiu CY; Schou MD; McMahon JH; Deeks SG; Fromentin R; Chomont N; Wykes MN; Rasmussen TA; Lewin SR
Front Immunol; 2023; 14():1123342. PubMed ID: 37056754
[TBL] [Abstract][Full Text] [Related]
10. HIV Reservoir Decay and CD4 Recovery Associated With High CD8 Counts in Immune Restored Patients on Long-Term ART.
Zhang LX; Jiao YM; Zhang C; Song JW; Fan X; Xu RN; Huang HH; Zhang JY; Wang LF; Zhou CB; Jin L; Shi M; Wang FS
Front Immunol; 2020; 11():1541. PubMed ID: 32793212
[No Abstract] [Full Text] [Related]
11. Antiretroviral therapy-induced dominant interleukin-2 HIV-1 Gag CD4+ T cell response: evidence of functional recovery of HIV-1-specific CD4+ T cells.
Tsalimalma K; Kordossis T; Choremi-Papadopoulou E
Scand J Immunol; 2011 Mar; 73(3):256-65. PubMed ID: 21204901
[TBL] [Abstract][Full Text] [Related]
12. Activated PD-1+ CD4+ T cells represent a short-lived part of the viral reservoir and predict poor immunologic recovery upon initiation of ART.
Eller MA; Hong T; Creegan M; Nau ME; Sanders-Buell E; Slike BM; Krebs SJ; Ratto-Kim S; McElrath MJ; Katabira ET; Bolton DL; Michael NL; Robb ML; Tovanabutra S; Baeten JM; Sandberg JK
AIDS; 2020 Feb; 34(2):197-202. PubMed ID: 31764072
[TBL] [Abstract][Full Text] [Related]
13. DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent Virus.
Thompson M; Heath SL; Sweeton B; Williams K; Cunningham P; Keele BF; Sen S; Palmer BE; Chomont N; Xu Y; Basu R; Hellerstein MS; Kwa S; Robinson HL
PLoS One; 2016; 11(10):e0163164. PubMed ID: 27711228
[TBL] [Abstract][Full Text] [Related]
14. Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells.
Hatano H; Jain V; Hunt PW; Lee TH; Sinclair E; Do TD; Hoh R; Martin JN; McCune JM; Hecht F; Busch MP; Deeks SG
J Infect Dis; 2013 Jul; 208(1):50-6. PubMed ID: 23089590
[TBL] [Abstract][Full Text] [Related]
15. Emergence of a distinct HIV-specific IL-10-producing CD8+ T-cell subset with immunomodulatory functions during chronic HIV-1 infection.
Clutton G; Yang H; Hancock G; Sande N; Holloway C; Angus B; von Delft A; Barnes E; Borrow P; Pellegrino P; Williams I; McMichael A; Dorrell L
Eur J Immunol; 2013 Nov; 43(11):2875-85. PubMed ID: 23897063
[TBL] [Abstract][Full Text] [Related]
16. Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load.
Oxenius A; Price DA; Dawson SJ; Günthard HF; Fischer M; Perrin L; Ramirez E; Fagard C; Hirschel B; Scullard G; Weber JN; McLean AR; Phillips RE;
AIDS; 2002 Nov; 16(17):2317-22. PubMed ID: 12441804
[TBL] [Abstract][Full Text] [Related]
17. Poor lymphoproliferative responses with low proportion of Gag-specific CD8 TEMRA cells in HIV-1-infected patients showing immunological and virological discordance despite prolonged suppression of plasma viremia.
Sachdeva N; Weinstein JE; Ashman M; Sachdeva M; Brewer TH; Gracia D; Asthana D
Viral Immunol; 2010 Feb; 23(1):49-61. PubMed ID: 20121402
[TBL] [Abstract][Full Text] [Related]
18. Discordant outcomes following failure of antiretroviral therapy are associated with substantial differences in human immunodeficiency virus-specific cellular immunity.
Price DA; Scullard G; Oxenius A; Braganza R; Beddows SA; Kazmi S; Clarke JR; Johnson GE; Weber JN; Phillips RE
J Virol; 2003 May; 77(10):6041-9. PubMed ID: 12719595
[TBL] [Abstract][Full Text] [Related]
19. Composition and function of T cell subpopulations are slow to change despite effective antiretroviral treatment of HIV disease.
Emu B; Moretto WJ; Hoh R; Krone M; Martin JN; Nixon DF; Deeks SG; McCune JM
PLoS One; 2014; 9(1):e85613. PubMed ID: 24465619
[TBL] [Abstract][Full Text] [Related]
20. Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children.
Ananworanich J; Puthanakit T; Suntarattiwong P; Chokephaibulkit K; Kerr SJ; Fromentin R; Bakeman W; Intasan J; Mahanontharit A; Sirivichayakul S; Chomont N;
AIDS; 2014 Apr; 28(7):1015-20. PubMed ID: 24384692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
